Nanjing Pharmaceutical Group Company Limited (SHA:600713)

China flag China · Delayed Price · Currency is CNY
4.930
-0.040 (-0.80%)
May 28, 2026, 3:00 PM CST
Market Cap6.45B -1.4%
Revenue (ttm)54.56B +1.1%
Net Income622.04M +5.6%
EPS0.41 -8.0%
Shares Out 1.31B
PE Ratio11.90
Forward PEn/a
Dividend0.17 (3.42%)
Ex-Dividend DateJun 30, 2025
Volume7,936,500
Open4.950
Previous Close4.970
Day's Range4.880 - 4.990
52-Week Range4.810 - 6.650
Beta0.31
Analystsn/a
Price Targetn/a
Earnings DateAug 28, 2026

About SHA:600713

Nanjing Pharmaceutical Group Company Limited engages in the drug distribution businesses in China. It also involved in the wholesale and retail of medical device distribution; pharmaceutical logistics; and internet drug retail business. The company was formerly known as NanJing Pharmaceutical Company Limited and change its name to Nanjing Pharmaceutical Group Company Limited in December 2025. Nanjing Pharmaceutical Group Company Limited was founded in 1951 and is based in Nanjing, China. [Read more]

Sector Healthcare
Founded 1951
Employees 4,697
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600713
Full Company Profile

Financial Performance

In 2025, SHA:600713's revenue was 54.96 billion, an increase of 2.36% compared to the previous year's 53.70 billion. Earnings were 624.83 million, an increase of 9.50%.

Financial Statements